மருத்துவ தகவல்கள் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quartesian Surpasses 250 Studies Employing Medrio s EDC Platform News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/ Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced today that they have deployed Medrio s cloud-based EDC platform for 265 clinical studies world-wide. Quartesian s partnership with Medrio began in 2009 and they were an early participant in the Medrio Partner Program providing expanded services to better support mutual sponsor and CRO customers. Quartesian has contributed to both product development and marketing during this long relationship as part of Medrio s Customer Advisory Board. Quartesian and Medrio understand the value of data-driven trials. Surpassing 250 studies together means that the data speaks for itself, said Nicole Latimer, CEO of Medrio. Quartesian continues to disrupt the clinical data services industry by unl

Stephen boccardoPrnewswire quartesianNicole latimerVp business developmentMedrio partner programClinical research organizationClinical data companyBusiness developmentCustomer advisoryDirect data captureCommercial strategyClinical dataநிக்கோல் ல்யாடிமர்வ்ப் வணிக வளர்ச்சிமருத்துவ ஆராய்ச்சி ஆர்கநைஸேஶந்மருத்துவ தகவல்கள் நிறுவனம்